1-12 of 12
F. Lauria
Close
Sort by
Journal Articles

PEG Intron Treatment in 90 Patients with Essential Thrombocythemia (ET) Final Report of a Phase II Study.

Luigi Gugliotta, MD, S. Bulgarelli, MD, N. Vianelli, MD, D. Russo, MD, A. Candoni, MD, S. Rupoli, MD, R. Latagliata, MD, S. Sacchi, MD, V. Martinelli, MD, E. De Biasi, MD, A. Bucalossi, MD, S. Mazzotta, MD, A. Tabilio, MD, F. Passamonti, MD, A. Grossi, MD, E. Cacciola, MD, R. Cacciola, MD, E. Pogliani, MD, F. Bonifazi, MD, R. Fanin, MD, P. Leoni, MD, F. Mandelli, MD, A. Zaccaria, MD, F. Lauria, MD, M. Lazzarino, MD, M. Gobbi, MD, A. Bosi, MD, P. Mazza, MD, G. Fincato, MD, P. Favini, MD, M. Baccarani, MD
Journal: Blood
Blood (2005) 106 (11): 2600.
https://doi.org/10.1182/blood.V106.11.2600.2600
Published: 2005
Journal Articles

Bone Marrow Evaluation According to the PVSG and WHO Criteria in 90 Essential Thrombocythemia (ET) Patients Treated with PEG Interferon alpha-2b. Preliminary Results.

Luigi Gugliotta, MD, S. Bulgarelli, MD, S. Asioli, MD, A. Tieghi, MD, G. Gardini, MD, E. Sabattini, MD, V. Franco, MD, E. Boveri, MD, H. M. Kvasnicka, MD, N. Vianelli, MD, A. Candoni, MD, R. Latagliata, MD, F. Passamonti, MD, S. Rupoli, MD, V. Martinelli, MD, A. Zaccaria, MD, F. Lauria, MD, E. De Biasi, MD, S. Sacchi, MD, M. Gobbi, MD, A. Tabilio, MD, E. Cacciola, MD, R. Cacciola, MD, A. Grossi, MD, P. Mazza, MD, F. Bonifazi, MD, P. Favini, F. Mandelli, MD, M. Baccarani, MD, J. Thiele, MD
Journal: Blood
Blood (2005) 106 (11): 4962.
https://doi.org/10.1182/blood.V106.11.4962.4962
Published: 2005
Journal Articles

Bone Marrow Biopsy and Aspirate Evaluation in 90 Patients with Essential Thrombocythemia Treated with PEG Interferon alpha-2b. Preliminary Results.

L. Gugliotta, S. Bulgarelli, A. Tieghi, S. Asioli, G. Gardini, N. Vianelli, A. Candoni, R. Latagliata, S. Rupoli, V. Martinelli, A. Zaccaria, E. De Biasi, S. Sacchi, F. Lauria, M. Miglino, F. Passamonti, A. Tabilio, E. Cacciola, A. Grossi, G. Pisapia, P. Favini, M. Baccarani
Journal: Blood
Blood (2004) 104 (11): 1523.
https://doi.org/10.1182/blood.V104.11.1523.1523
Published: 2004
Journal Articles

The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function

A Cambiaggi, AM Orengo, R Meazza, S Sforzini, PL Tazzari, F Lauria, D Raspadori, R Zambello, G Semenzato, L Moretta, S Ferrini
Journal: Blood
Blood (1996) 87 (6): 2369–2375.
https://doi.org/10.1182/blood.V87.6.2369.bloodjournal8762369
Published: 1996
Journal Articles

Phenotypic analysis of hairy cell leukemia: "variant" cases express the interleukin-2 receptor beta chain, but not the alpha chain (CD25)

D de Totero, PL Tazzari, F Lauria, D Raspadori, PF di Celle, A Carbone, M Gobbi, R Foa
Journal: Blood
Blood (1993) 82 (2): 528–535.
https://doi.org/10.1182/blood.V82.2.528.528
Published: 1993
Journal Articles

Heterogeneous immunophenotype of granular lymphocyte expansions: differential expression of the CD8 alpha and CD8 beta chains [see comments]

D de Totero, PL Tazzari, JP DiSanto, PF di Celle, D Raspadori, R Conte, M Gobbi, GB Ferrara, N Flomenberg, F Lauria
Journal: Blood
Blood (1992) 80 (7): 1765–1773.
https://doi.org/10.1182/blood.V80.7.1765.1765
Published: 1992
Journal Articles

Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease

R Foa, MT Fierro, A Cesano, A Guarini, M Bonferroni, D Raspadori, R Miniero, F Lauria, F Gavosto
Journal: Blood
Blood (1991) 78 (4): 1041–1046.
https://doi.org/10.1182/blood.V78.4.1041.1041
Published: 1991
Journal Articles

Alternative BCR/ABL transcripts in chronic myeloid leukemia [letter; comment]

A Zaccaria, A Tassinari, N Testoni, F Lauria, S Tura, R Algeri, A Guerrasio, C Rosso, G Saglio
Journal: Blood
Blood (1990) 76 (8): 1663–1665.
https://doi.org/10.1182/blood.V76.8.1663b.1663b
Published: 1990
Journal Articles

Analysis of T-cell receptor beta chain (T beta) gene rearrangements demonstrates the monoclonal nature of T-cell chronic lymphoproliferative disorders

R Foa, PG Pelicci, N Migone, F Lauria, G Pizzolo, F Flug, DM 2d Knowles, R Dalla- Favera
Journal: Blood
Blood (1986) 67 (1): 247–250.
https://doi.org/10.1182/blood.V67.1.247.247
Published: 1986
Journal Articles

Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population

R Foa, M Giovarelli, C Jemma, MT Fierro, P Lusso, ML Ferrando, F Lauria, G Forni
Journal: Blood
Blood (1985) 66 (3): 614–619.
https://doi.org/10.1182/blood.V66.3.614.614
Published: 1985
Journal Articles

Effect of a thymic factor on T lymphocytes in B cell chronic lymphocytic leukemia: in vitro and in vivo studies

F Lauria, D Raspadori, S Tura
Journal: Blood
Blood (1984) 64 (3): 667–671.
https://doi.org/10.1182/blood.V64.3.667.667
Published: 1984
Journal Articles

Staging of chronic lymphocytic leukemia

M Baccarani, M Cavo, M Gobbi, F Lauria, S Tura
Journal: Blood
Blood (1982) 59 (6): 1191–1196.
https://doi.org/10.1182/blood.V59.6.1191.1191
Published: 1982